Apr 01, 2020
Global Cancer Generics Market, Drug Dosage, Price & Opportunity Insight 2026
Mar 11, 2020
Generics Global Industry Almanac 2014-2023
Feb 02, 2020
Geneyork Pharmaceutical Announces U.S. Launch of Generic Version of Deltasone® (Prednisone) Tablets
Jan 07, 2020
Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future
Jan 06, 2020
Generics Market-Focus on Value-Added Medicines-Supergenerics, 2019-2030
Dec 26, 2019
FPP Signs Development and Supply Agreement with Agenix
Oct 30, 2019
FDA Approves First Generic Version of Anti-Anxiety Medicine for Dogs
Oct 28, 2019
Oakrum Pharma and SunGen Pharma Announce U.S. Launch of Generic Version of Medrol® (Methylprednisolone)
Oct 17, 2019
Tulane Law School's Copyright Lab Leverages the dtSearch® Engine with Contegra Development Work for Durationator® Worldwide Copyright System
Oct 16, 2019
FPP, LLC Inks ANDA Generic Deal
Oct 16, 2019
Statement from Acting FDA Commissioner Ned Sharpless, M.D., on continued progress enhancing patient access to high-quality, low-cost generic drugs
Sep 20, 2019
Pharmaceuticals Continuous Manufacturing Market Report 2019 - Implications for the Generics Market
Sep 18, 2019
The global generic oncology drugs market is expected to reach US$ 36,029.60 Mn in 2027 from US$ 21,200.00 in 2018
May 29, 2019
New Report: Prices of Canadian Generic Medicines Below International Average
Mar 19, 2019
CGPA Welcomes Progress Towards National Pharmacare in Federal Budget 2019
Jan 31, 2019
USP Announces Generics Access Plan
Jan 23, 2019
Global Autism Research Report 2019-2021: API Manufacturers, Marketed and Phase III Drugs Landscape - Forecasted Sales & API Manufacturer Details by Country
Jan 16, 2019
FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy
Dec 20, 2018
Competition Bureau completes abuse of dominance investigation into practices of Celgene, Pfizer and Sanofi
Oct 09, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines